paclitaxel,carboplatin,nivolumab
bms
['sclc', 'nadim', 'nivolumab', 'nadim ii', 'nivo', 'nsclc']
nivolumab + chemotherapy versus chemotherapy as neoadjuvant treatment for resectable stage iiia nsclc: primary endpoint results of pathological complete response (pcr) from phase ii nadim ii trial #asco22 pcr = os 
Medicina Interna - Oncología Clínica - Profesor Titular @UPBColombia - Clínica Astorga. #Medellín / #Colombia mlujanonco@gmail.com #OncTwitter #Metaanalysis